Correlation Between ABVC Biopharma and Surrozen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ABVC Biopharma and Surrozen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ABVC Biopharma and Surrozen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ABVC Biopharma and Surrozen, you can compare the effects of market volatilities on ABVC Biopharma and Surrozen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ABVC Biopharma with a short position of Surrozen. Check out your portfolio center. Please also check ongoing floating volatility patterns of ABVC Biopharma and Surrozen.

Diversification Opportunities for ABVC Biopharma and Surrozen

0.2
  Correlation Coefficient

Modest diversification

The 3 months correlation between ABVC and Surrozen is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding ABVC Biopharma and Surrozen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Surrozen and ABVC Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ABVC Biopharma are associated (or correlated) with Surrozen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Surrozen has no effect on the direction of ABVC Biopharma i.e., ABVC Biopharma and Surrozen go up and down completely randomly.

Pair Corralation between ABVC Biopharma and Surrozen

Given the investment horizon of 90 days ABVC Biopharma is expected to generate 1.03 times more return on investment than Surrozen. However, ABVC Biopharma is 1.03 times more volatile than Surrozen. It trades about 0.13 of its potential returns per unit of risk. Surrozen is currently generating about -0.02 per unit of risk. If you would invest  59.00  in ABVC Biopharma on December 29, 2024 and sell it today you would earn a total of  27.00  from holding ABVC Biopharma or generate 45.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

ABVC Biopharma  vs.  Surrozen

 Performance 
       Timeline  
ABVC Biopharma 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in ABVC Biopharma are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, ABVC Biopharma exhibited solid returns over the last few months and may actually be approaching a breakup point.
Surrozen 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Surrozen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

ABVC Biopharma and Surrozen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ABVC Biopharma and Surrozen

The main advantage of trading using opposite ABVC Biopharma and Surrozen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ABVC Biopharma position performs unexpectedly, Surrozen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Surrozen will offset losses from the drop in Surrozen's long position.
The idea behind ABVC Biopharma and Surrozen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities